Cardiac and systemic sympathetic activity in response to clonidine in human heart failure

Journal of the American College of Cardiology

Volumn 33, Issue 1, 1999, Pages 186-191

  Azevedo, Eduardo R ^a   Newton, Gary E ^a   Parker, John D ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; IMIDAZOLINE DERIVATIVE; NORADRENALIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEART HEMODYNAMICS; HEART INNERVATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROGNOSIS; SYMPATHETIC TONE;

ADRENERGIC ALPHA-AGONISTS; CARDIOMYOPATHY, DILATED; CLONIDINE; CORONARY CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NOREPINEPHRINE; PROGNOSIS; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0032898610     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00524-5     Document Type: Article

References (32)

1. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23.
2. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995;26:1257-63.
3. Esler M, Jennings G, Korner P, Blombery P, Sacharias N, Leonard P. Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol 1984;247:E21-8.
4. 1-receptor down-regulation in heart failure. Circ Res 1986;59:297-309.
5. Mann DL, Kent RL, Parsons B, Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992;85:790-804.
6. Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1991;325:618-24.
7. Waagstein F, Bristow MR, Swedberg K, et al., for the Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993;342:1441-6.
8. Packer M, Bristow MR, Cohn JN, et al., for the U.S. Carvediol Heart Failure Study Group. The effect of carvediolol on morbidity and mortality and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
9. 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure. Circulation 1996;94:353-8.
10. Kaye DM, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol 1994;23:570-8.
11. Giles TD, Iteld BJ, Mautner RK, Rognoni PA, Dillenkoffer RL. Short-term effects of intravenous clonidine in congestive heart failure. Clin Pharmacol Ther 1981;30:724-8.
12. Lang CC, Stein CM, He HB, et al. Blunted blood pressure response to central sympathoinhibition in normotensive blacks: increased importance of nonsympathetic factors in blood pressure maintenance in blacks. Hypertension 1997;30:157-62.
13. Isaac L. Clonidine in the central nervous system: site and mechanism of hypotensive action. J Cardiovasc Pharmacol 1980;2 Suppl 1:S5-19.
14. Svensson TH, Bunney BS, Aghajanian GK. Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res 1975;92:291-306.
15. Wallin BG, Frisk-Holmberg M. The antihypertensive mechanism of clonidine in man: evidence against a generalized reduction of sympathetic activity. Hypertension 1981;3:340-6.
16. Kooner JS, Birch R, Frankel HL, Peart WS, Mathias CJ. Hemodynamic and neurohormonal effects of clonidine in patients with preganglionic and postganglionic sympathetic lesions: evidence for a central sympatholytic action. Circulation 1991;84:75-83.
17. Parker JD, Newton GE, Landzberg JS, Floras JS, Colucci WS. Functional significance of presynaptic alpha-adrenergic receptors in the failing and non-failing human left ventricle. Circulation 1995;92:1793-800.
18. Weiss JL, Frederiksen JW, Weisfeldt ML. Hemodynamic determinants of the time course of fall in canine left ventricular pressure. J Clin Invest 1976;58:751-60.
19. Mirsky I. Assessment of diastolic function: suggested methods and future considerations. Circulation 1984;69:836-41.
20. Ganz W, Tamura K, Marcus HS, Donoso R, Swan HJC. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation 1971;44:181-95.
21. Hasking GJ, Esler MD, Jennings GJ, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986;73:615-21.
22. Newton GE, Tong JS, Schofield AM, Baines AD, Floras JS, Parker JD. Digoxin reduces cardiac sympathetic activity in severe congestive heart failure. J Am Coll Cardiol 1996;28:155-61.
23. Newton GE, Parker JD. Cardiac sympathetic responses to acute vasodilation: normal ventricular function versus congestive heart failure. Circulation 1996;94:3161-7.
24. Hoffman BB, Lefkowitz RJ. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Goodman Gilman A, Limbird LE, editors. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw-Hill, 1996;199-248.
25. Lang CC, Rayos GH, Chomsky DB, Wood AJ, Wilson JR. Effect of sympathoinhibition on exercise performance in patients with heart failure. Circulation 1997;96:238-45.
26. Manolis AJ, Olympios C, Sifaki M, et al. Suppressing sympathetic activation in congestive heart failure: a new therapeutic strategy. Hypertension 1995; 26:719-24.
27. Haber HL, Simek CL, Gimple LW, et al. Why do patients with congestive heart failure tolerate the initiation of beta-blocker therapy? Circulation 1993;88:1610-9.
28. Gleason WL, Braunwald E. Studies of the first derivative of the ventricular pressure pulse in man. J Clin Invest 1961;41:80-91.
29. Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure: dose-response relationships and comparison to nitroprusside. J Clin Invest 1985;75:643-9.
30. Gaasch WH, Blaustein AS, Andrias CW, Donahue RP, Avitall B. Myocardial relaxation. II. Hemodynamic determinants of rate of left ventricular isovolumic pressure decline. Am J Physiol 1980;239:H1-6.
31. Herrmann HC, Ruddy TD, Dec GW, Strauss HW, Boucher CA, Fifer MA. Diastolic function in patients with severe heart failure: comparison of the effects of enoximone and nitroprusside. Circulation 1987;75:1214-21.
32. Feldman MD, Alderman JD, Aroesty JM, et al. Depression of systolic and diastolic myocardial reserve during atrial pacing tachycardia in patients with dilated cardiomyopathy. J Clin Invest 1988;82:1661-9.